ERR open access journal advertisement
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


EUROPEAN RESPIRATORY REVIEW, 2008;17: 157-162. doi:10.1183/09059180.00010909
© 2008 the European Respiratory Society

This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrow Request Permissions
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Sheppard, D.
PubMed
Right arrow Articles by Sheppard, D.

The role of integrins in pulmonary fibrosis

D. Sheppard

CORRESPONDENCE: D. Sheppard, University of California San Francisco, UCSF Box 2922, San Francisco, CA 94143-2922, USA. Fax: 1 4155144278. E-mail: dean.sheppard{at}ucsf.edu

Integrins are a large family of transmembrane glycoprotein receptors initially identified as mediators of cell adhesion and tissue integrity. However, it is now known that the primary function of integrins in mammals is to act as signalling proteins.

Signals from integrins are known to play critical roles in virtually every aspect of the behaviour of epithelial cells and in the development of certain pathological conditions, including pulmonary fibrosis. In this respect, the interaction between transforming growth factor-β, which is known to be pivotal in the development of pulmonary fibrosis, and the integrin {alpha}Vβ6 is of particular interest.

Integrin {alpha}Vβ6 is responsible for the activation of constitutively expressed latent transforming growth factor-β by a mechanism that allows for temporal and spatial activity control.

There is increasing evidence that this mechanism plays a critical role in the pathological activity of transforming growth factor-β. Although other activation mechanisms have been identified, studies suggest that {alpha}Vβ6-mediated activation of transforming growth factor-β is necessary for the development of fibrosis in lung-disease models. The data from such studies imply that integrins may be attractive targets for intervention in pulmonary fibrotic diseases, such as idiopathic pulmonary fibrosis.

KEYWORDS: {alpha}Vβ6, epithelial-to-mesenchymal transition, transforming growth factor-β







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the European Respiratory Society.